ARS Pharmaceuticals, Inc. (SPRY) stock
Close on Nov 12, 2026Market cap $378.89MP/E –Yield –
ARS Pharmaceuticals statistics
72 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 8, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 1.97
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- -4.13%
- 10.9%
- Shares Change (QoQ)
- 0.82%
- 0.51%
- Float
- 53M
- 49M
- Shares Held by Insiders
- 46.7%
- 12.1%
- Shares Held by Institutions
- 91.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 19M
- –
- Short Interest Change
- -4.18%
- -0.76%
- Short % of Float
- 35.9%
- 9.04%
- Short % of Shares Outstanding
- 19.1%
- 6.30%
- Days to Cover
- 11.09
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $13.15
- –
- 52-Week Low
- $2.44
- –
- 20-Day Moving Average
- $3.62
- –
- 50-Day Moving Average
- $4.11
- –
- 200-Day Moving Average
- $7.07
- –
- Average True Range (14)
- $0.36
- –
- Price Change (1 Week)
- 43.8%
- 1.51%
- Price Change (1 Month)
- -3.05%
- -2.35%
- Price Change (3 Months)
- -32.6%
- -21.1%
- Price Change (6 Months)
- -52.0%
- -22.6%
- Price Change (YTD)
- -67.3%
- -22.6%
- Price Change (1 Year)
- -56.6%
- -20.7%
- Price Change (3 Years)
- -4.75%
- -27.4%
- Price Change (5 Years)
- -54.9%
- -77.3%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 1.18
- 0.79
- Relative Strength Index (14)
- 51.6
- 44.7
- Volatility (1 Year)
- 78.1%
- 80.4%
- Beta (5 Years)
- 1.43
- 1.07
MarginsIndustry
- EBITDA Margin
- -160.2%
- -27.7%
- FCF Margin
- -149.9%
- -9.20%
Returns on capitalIndustry
- Return on Equity (ROE)
- -294.6%
- -51.2%
- Return on Assets (ROA)
- -64.0%
- -40.6%
- Return on Capital Employed (ROCE)
- -105.7%
- -38.0%
Financial positionIndustry
- Current Ratio
- 3.25
- 3.30
- Quick Ratio
- 2.94
- 2.42
GrowthIndustry
- Revenue Growth (YoY)
- -14.5%
- 7.01%
- Revenue Growth (3Y CAGR)
- 300.1%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.39
- 0.40
- Revenue Per Employee
- $773.01K
- $429.29K
- Profits Per Employee
- -$1.26M
- -$683.67K
- Employee Count
- 158
- 75
- WACC
- 12.1%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $138.35M
- $17.46M
- Net Cash Per Share
- $1.39
- $0.72
- Equity (Book Value)
- -$11.96M
- $53.27M
- Book Value Per Share
- -$0.12
- $1.50
- Tangible Book Value
- -$25.58M
- $26.82M
- Working Capital
- $146.13M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- $0
- -$944.00K
- FCF Per Share
- -$1.84
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -52.8%
- -20.8%
- FCF Yield
- -48.3%
- -9.58%
Scores and fair valueIndustry
- Altman Z-Score
- -3.07
- 0.30
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | SPRY | S&P 500 | Difference | SPRY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.9% | -2.7% | −6.2 pts | ||
| 3 months | -37.0% | -1.7% | −35.3 pts | ||
| Year to date | -67.3% | +11.9% | −79.2 pts | ||
| 1 year | -57.4% | +12.0% | −69.4 pts | ||
| 3 years | +2.1% | +78.2% | −76.0 pts | +0.7% | +21.2% |
| 5 years | -54.9% | +73.2% | −128.1 pts | -14.7% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
19M SPRY shares were sold short on Oct 30, 2026, down 4.2% from the previous report, or 35.85% of the shares available to trade. At recent volumes it would take 11.1 days to buy them back. Over the last 20 sessions, 49.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 18,990,650 | -4.2% | 1,712,099 | 11.1 |
| Oct 15, 2026 | 19,819,885 | -6.5% | 1,577,588 | 12.6 |
| Sep 30, 2026 | 21,190,047 | -8.2% | 1,316,280 | 16.1 |
| Sep 15, 2026 | 23,073,209 | -0.6% | 1,487,857 | 15.5 |
| Aug 31, 2026 | 23,209,349 | +1.1% | 1,641,523 | 14.1 |
| Aug 14, 2026 | 22,952,291 | +7.0% | 2,080,702 | 11.0 |
| Jul 31, 2026 | 21,451,536 | -5.4% | 2,757,361 | 7.8 |
| Jul 15, 2026 | 22,669,317 | +4.3% | 1,481,660 | 15.3 |
| Jun 30, 2026 | 21,733,764 | -5.9% | 2,541,223 | 8.6 |
| Jun 15, 2026 | 23,090,842 | -9.4% | 1,311,462 | 17.6 |
| May 29, 2026 | 25,495,252 | -1.6% | 1,811,091 | 14.1 |
| May 15, 2026 | 25,912,002 | -1.1% | 1,948,044 | 13.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?